Day: December 2, 2024

NovelMed Receives FDA IND Approval for NM8074 (Ruxoprubart), the First Anti-Bb Alternative Pathway Blocker for Treating Primary Immunoglobulin A Nephropathy (IgAN): A Renal Disorder

Canon Medical Informatics Selected by Leading U.S. Health System to Standardize 3D Processing Capabilities in the Cloud Using Vitrea Advanced Visualization Platform

MINNETONKA, Minn., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Canon Medical Informatics, Inc. has been selected by a leading U.S. health...

Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

The engagement with an EU-based GMP manufacturing facility enables timely production and preparation for clinical trial. The EU-based GMP manufacturer...

Ainos, Inc. Announces Strategic Partnership with Taiwan Tanabe Seiyaku to Advance Manufacturing and Taiwan Market Promotion of Sjögren’s Syndrome Drug

San Diego, California--(Newsfile Corp. - December 2, 2024) - Ainos, Inc. (NASDAQ: AIMD) (NASDAQ: AIMDW) ("Ainos" or the "Company"), an...

error: Content is protected !!